PRECURSOR CHEMICAL ANNUAL RETURNS 2012

This form should be completed and returned to annualdrugreturns@homeoffice.gsi

2013

IMPORTANT INFORMATION:

Accurate returns are essential and as such these forms must be cleared by a Senior Management Representative o

This completed form must be returned electronically to annualdrugreturns@homeoffice.gsi.gov.uk. Hardcopy p

accepted. Only excel format files

This spreadsheet should be 'Saved As' from the website and saved with a file name of, "YYYY-MM-DD - Precursor
- Company Name",
e.g."2012-05-01 - Precursor Chemicals Annual Returns 2012 - Perfect Pharmaceuticals Ltd"

Please return the completed form to the above email address as an 'Excel' file and NOT as a 'PDF' file
The subject line of the returned email should read "YYYY-MM-DD – Precursor Chemicals ANNUAL RETURNS 2
"2012-07-04 - Precursor Chemicals Annual Returns 2012 - Perfect Pharmaceuticals Ltd"
It is imperative that every relevant domestic licence holder completes the annual return exercise

COMPANY DETAILS (mandatory):

Company
Company Name: Registered
Address:

Site(s) to which
these details refer
(this return must
Telephone:
cover all your
companies
licenced sites): Please list all your licensed sites here.

Email:

Completed by: >>>>> Position:

Checked by: >>>>> Position:

L RETURNS 2012

urns@homeoffice.gsi.gov.uk by 28th February

ON:

Management Representative once completed

eoffice.gsi.gov.uk. Hardcopy postal submissions will not be

at files

, "YYYY-MM-DD - Precursor Chemicals Annual Returns 2012

s Ltd"

T as a 'PDF' file
icals ANNUAL RETURNS 2012 (COMPANY NAME)", e.g.
d"
n exercise

atory):
 PRECURSORS
ANNUAL RETURN for the period 1 January to 31 Decembe

NAME OF CHEMICAL…....…EPHEDRINE RAW MATERIAL ………………………………

NAME OF COMPANY …………..………………………………………………………………………

ADDRESS………………… ……………………..……………………………………………………………

…………………………..………………………………………………………

All quantities should be recorded in terms of BASE CHEMICAL AND IN KILOGRAMS

A Opening stock

B Total quantity manufactured

C Quantity imported and from which country

(Incl EU countries) ……………………………………
…………………………………..
………………………………….
…………………………………..
…………………………………..
………………………………….
…………………………………..
………………………………….
…………………………………..
…………………………………..
………………………………….
…………………………………..
………………………………….
 …………………………………..
…………………………………..
………………………………….
…………………………………..

D Quantity exported and from which country

(Incl EU countries)….. …………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..

E Quantity supplied to UK licensees

F Quantity received from UK suppliers

G 1. Quantity used in the year…………………………………………

1(a) Purposes for which it was used

…………………………………….
 …………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….

2. Quantity remaining in stock at 31 December 2012…………

H 1. Approximation of quantity required for use in 2013……………

2. Purposes for which it will be required.

…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….

This form should be completed and returned to annualdrugreturns@

y to 31 December 2013

……………………………………………………………………

……………………………………

……………………………………

……………………………………

GRAMS

. KGS

· KGS

· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
 KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS

· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS

· KGS

· KGS

· KGS

. KGS
 . KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS

· KGS

· KGS

. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS

nnualdrugreturns@homeoffice.gsi.gov.uk by 28 February 2013

 PRECURSORS
ANNUAL RETURN for the period 1 January to 31 Decembe

NAME OF CHEMICAL…....…EPHEDRINE PREPARATIONS ………………………………

NAME OF COMPANY …………..………………………………………………………………………

ADDRESS………………… ……………………..……………………………………………………………

…………………………..………………………………………………………

All quantities should be recorded in terms of BASE CHEMICAL AND IN KILOGRAMS

A Opening stock

B Total quantity manufactured

C Quantity imported and from which country

(Incl EU countries) ……………………………………
…………………………………..
………………………………….
…………………………………..
…………………………………..
………………………………….
…………………………………..
………………………………….
…………………………………..
…………………………………..
………………………………….
…………………………………..
………………………………….
 …………………………………..
…………………………………..
………………………………….
…………………………………..

D Quantity exported and from which country

(Incl EU countries)….. …………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..

E Quantity supplied to UK licensees

F Quantity received from UK suppliers

G 1. Quantity used in the year…………………………………………

1(a) Purposes for which it was used

…………………………………….
 …………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….

2. Quantity remaining in stock at 31 December 2012…………

H 1. Approximation of quantity required for use in 2013……………

2. Purposes for which it will be required.

…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….

This form should be completed and returned to annualdrugreturns@

y to 31 December 2013

……………………………………………………………………

……………………………………

……………………………………

……………………………………

GRAMS

. KGS

· KGS

· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
 KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS

· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS

· KGS

· KGS

· KGS

. KGS
 . KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS

· KGS

· KGS

. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS

nnualdrugreturns@homeoffice.gsi.gov.uk by 28 February 2013

 PRECURSORS
ANNUAL RETURN for the period 1 January to 31 Decembe

NAME OF CHEMICAL…....…ERGOMETRINE ………………………………………………

NAME OF COMPANY …………..………………………………………………………………………

ADDRESS………………… ……………………..……………………………………………………………

…………………………..………………………………………………………

All quantities should be recorded in terms of BASE CHEMICAL AND IN KILOGRAMS

A Opening stock

B Total quantity manufactured

C Quantity imported and from which country

(Incl EU countries) ……………………………………
…………………………………..
………………………………….
…………………………………..
…………………………………..
………………………………….
…………………………………..
………………………………….
…………………………………..
…………………………………..
………………………………….
…………………………………..
………………………………….
 …………………………………..
…………………………………..
………………………………….
…………………………………..

D Quantity exported and from which country

(Incl EU countries)….. …………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..

E Quantity supplied to UK licensees

F Quantity received from UK suppliers

G 1. Quantity used in the year…………………………………………

1(a) Purposes for which it was used

…………………………………….
 …………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….

2. Quantity remaining in stock at 31 December 2012…………

H 1. Approximation of quantity required for use in 2013……………

2. Purposes for which it will be required.

…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….

This form should be completed and returned to annualdrugreturns@

y to 31 December 2013

…………………………………………………

……………………………………

……………………………………

……………………………………

GRAMS

. KGS

· KGS

· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
 KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS

· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS

· KGS

· KGS

· KGS

. KGS
 . KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS

· KGS

· KGS

. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS

nnualdrugreturns@homeoffice.gsi.gov.uk by 28 February 2013

 PRECURSORS
ANNUAL RETURN for the period 1 January to 31 Decembe

NAME OF CHEMICAL…....…ERGOTAMINE …………………………………………………

NAME OF COMPANY …………..………………………………………………………………………

ADDRESS………………… ……………………..……………………………………………………………

…………………………..………………………………………………………

All quantities should be recorded in terms of BASE CHEMICAL AND IN KILOGRAMS

A Opening stock

B Total quantity manufactured

C Quantity imported and from which country

(Incl EU countries) ……………………………………
…………………………………..
………………………………….
…………………………………..
…………………………………..
………………………………….
…………………………………..
………………………………….
…………………………………..
…………………………………..
………………………………….
…………………………………..
………………………………….
 …………………………………..
…………………………………..
………………………………….
…………………………………..

D Quantity exported and from which country

(Incl EU countries)….. …………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..

E Quantity supplied to UK licensees

F Quantity received from UK suppliers

G 1. Quantity used in the year…………………………………………

1(a) Purposes for which it was used

…………………………………….
 …………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….

2. Quantity remaining in stock at 31 December 2012…………

H 1. Approximation of quantity required for use in 2013……………

2. Purposes for which it will be required.

…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….

This form should be completed and returned to annualdrugreturns@

y to 31 December 2013

…………………………………………………

……………………………………

……………………………………

……………………………………

GRAMS

. KGS

· KGS

· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
 KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS

· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS

· KGS

· KGS

· KGS

. KGS
 . KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS

· KGS

· KGS

. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS

nnualdrugreturns@homeoffice.gsi.gov.uk by 28 February 2013

 PRECURSORS
ANNUAL RETURN for the period 1 January to 31 Decembe

NAME OF CHEMICAL…....…LYSERGIC ACID ………………………………………………

NAME OF COMPANY …………..………………………………………………………………………

ADDRESS………………… ……………………..……………………………………………………………

…………………………..………………………………………………………

All quantities should be recorded in terms of BASE CHEMICAL AND IN KILOGRAMS

A Opening stock

B Total quantity manufactured

C Quantity imported and from which country

(Incl EU countries) ……………………………………
…………………………………..
………………………………….
…………………………………..
…………………………………..
………………………………….
…………………………………..
………………………………….
…………………………………..
…………………………………..
………………………………….
…………………………………..
………………………………….
 …………………………………..
…………………………………..
………………………………….
…………………………………..

D Quantity exported and from which country

(Incl EU countries)….. …………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..

E Quantity supplied to UK licensees

F Quantity received from UK suppliers

G 1. Quantity used in the year…………………………………………

1(a) Purposes for which it was used

…………………………………….
 …………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….

2. Quantity remaining in stock at 31 December 2012…………

H 1. Approximation of quantity required for use in 2013……………

2. Purposes for which it will be required.

…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….

This form should be completed and returned to annualdrugreturns@

y to 31 December 2013

……………………………………………………

……………………………………

……………………………………

……………………………………

GRAMS

. KGS

· KGS

· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
 KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS

· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS

· KGS

· KGS

· KGS

. KGS
 . KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS

· KGS

· KGS

. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS

nnualdrugreturns@homeoffice.gsi.gov.uk by 28 February 2013

 PRECURSORS
ANNUAL RETURN for the period 1 January to 31 December 2

NAME OF CHEMICAL…....…1-PHENYL-2-PROPANONE (BMK) ……………………………

NAME OF COMPANY …………..……………………………………………………………………………

ADDRESS………………… ……………………..…………………………………………………………………

…………………………..……………………………………………………………

All quantities should be recorded in terms of BASE CHEMICAL AND IN KILOGRAMS

A Opening stock

B Total quantity manufactured

C Quantity imported and from which country

(Incl EU countries) ……………………………………
…………………………………..
………………………………….
…………………………………..
…………………………………..
………………………………….
…………………………………..
………………………………….
…………………………………..
…………………………………..
 ………………………………….
…………………………………..
………………………………….
…………………………………..
…………………………………..
………………………………….
…………………………………..

D Quantity exported and from which country

(Incl EU countries)….. …………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..

E Quantity supplied to UK licensees

F Quantity received from UK suppliers

G 1. Quantity used in the year…………………………………………

1(a) Purposes for which it was used

…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….

2. Quantity remaining in stock at 31 December 2012…………

H 1. Approximation of quantity required for use in 2013……………

2. Purposes for which it will be required.

…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
 …………………………………….

This form should be completed and returned to annualdrugreturns@hom

y to 31 December 2013

…………………………………………………………………………

……………………………………

……………………………………

……………………………………

GRAMS

. KGS

· KGS

· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS

· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS

· KGS
· KGS

· KGS

. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS

· KGS

· KGS

. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
 . KGS

nualdrugreturns@homeoffice.gsi.gov.uk by 28 February 2013

 PRECURSORS
ANNUAL RETURN for the period 1 January to 31 December 2

NAME OF CHEMICAL…....…PSEUDOEPHEDRINE RAW MATERIALS …………………

NAME OF COMPANY …………..…………………………………………………………………………

ADDRESS………………… ……………………..………………………………………………………………

…………………………..…………………………………………………………

All quantities should be recorded in terms of BASE CHEMICAL AND IN KILOGRAMS

A Opening stock

B Total quantity manufactured

C Quantity imported and from which country

(Incl EU countries) ……………………………………
…………………………………..
………………………………….
…………………………………..
…………………………………..
………………………………….
…………………………………..
………………………………….
…………………………………..
 …………………………………..
………………………………….
…………………………………..
………………………………….
…………………………………..
…………………………………..
………………………………….
…………………………………..

D Quantity exported and from which country

(Incl EU countries)….. …………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
E Quantity supplied to UK licensees

F Quantity received from UK suppliers

G 1. Quantity used in the year…………………………………………

1(a) Purposes for which it was used

…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….

2. Quantity remaining in stock at 31 December 2012…………

H 1. Approximation of quantity required for use in 2013……………

2. Purposes for which it will be required.

…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
 …………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….

This form should be completed and returned to annualdrugreturns@ho

ry to 31 December 2013

ALS …………………………………………………………………………

……………………………………

……………………………………

……………………………………

GRAMS

. KGS

· KGS

· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS

· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
· KGS

· KGS

· KGS

. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS

· KGS

· KGS

. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
 . KGS
. KGS
. KGS
. KGS
. KGS

nnualdrugreturns@homeoffice.gsi.gov.uk by 28 February 2013

 PRECURSORS
ANNUAL RETURN for the period 1 January to 31 December 2

NAME OF CHEMICAL…....…PSEUDOEPHEDRINE PREPARATIONS ……………………

NAME OF COMPANY …………..…………………………………………………………………………

ADDRESS………………… ……………………..………………………………………………………………

…………………………..…………………………………………………………

All quantities should be recorded in terms of BASE CHEMICAL AND IN KILOGRAMS

A Opening stock

B Total quantity manufactured

C Quantity imported and from which country

(Incl EU countries) ……………………………………
…………………………………..
………………………………….
…………………………………..
…………………………………..
………………………………….
…………………………………..
………………………………….
…………………………………..
 …………………………………..
………………………………….
…………………………………..
………………………………….
…………………………………..
…………………………………..
………………………………….
…………………………………..

D Quantity exported and from which country

(Incl EU countries)….. …………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
E Quantity supplied to UK licensees

F Quantity received from UK suppliers

G 1. Quantity used in the year…………………………………………

1(a) Purposes for which it was used

…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….

2. Quantity remaining in stock at 31 December 2013…………

H 1. Approximation of quantity required for use in 2013……………

2. Purposes for which it will be required.

…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
 …………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….

This form should be completed and returned to annualdrugreturns@ho

ry to 31 December 2013

NS …………………………………………………………………………

……………………………………

……………………………………

……………………………………

GRAMS

. KGS

· KGS

· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS

· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
· KGS

· KGS

· KGS

. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS

· KGS

· KGS

. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
 . KGS
. KGS
. KGS
. KGS
. KGS

nnualdrugreturns@homeoffice.gsi.gov.uk by 28 February 2013

 PRECURSORS
ANNUAL RETURN for the period 1 January to 31 December 2

NAME OF CHEMICAL…....…N-ACETYLANTHRANILLIC ACID ………………………………

NAME OF COMPANY …………..……………………………………………………………………………

ADDRESS………………… ……………………..…………………………………………………………………

…………………………..……………………………………………………………

All quantities should be recorded in terms of BASE CHEMICAL AND IN KILOGRAMS

A Opening stock

B Total quantity manufactured

C Quantity imported and from which country

(Incl EU countries) ……………………………………
…………………………………..
………………………………….
…………………………………..
…………………………………..
………………………………….
…………………………………..
………………………………….
…………………………………..
…………………………………..
 ………………………………….
…………………………………..
………………………………….
…………………………………..
…………………………………..
………………………………….
…………………………………..

D Quantity exported and from which country

(Incl EU countries)….. …………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..

E Quantity supplied to UK licensees

F Quantity received from UK suppliers

G 1. Quantity used in the year…………………………………………

1(a) Purposes for which it was used

…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….

2. Quantity remaining in stock at 31 December 2013…………

H 1. Approximation of quantity required for use in 2013……………

2. Purposes for which it will be required.

…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
 …………………………………….

This form should be completed and returned to annualdrugreturns@hom

y to 31 December 2013

………………………………………………………………………

……………………………………

……………………………………

……………………………………

GRAMS

. KGS

· KGS

· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS

· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS

· KGS
· KGS

· KGS

. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS

· KGS

· KGS

. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
 . KGS

nualdrugreturns@homeoffice.gsi.gov.uk by 28 February 2013

 PRECURSORS
ANNUAL RETURN for the period 1 January to 31 December 2

NAME OF CHEMICAL…....…3-4 METHYLENEDIOXY-PHENYLPROPAN-2-ONE (PMK)…

NAME OF COMPANY …………..……………………………………………………………………………

ADDRESS………………… ……………………..…………………………………………………………………

…………………………..……………………………………………………………

All quantities should be recorded in terms of BASE CHEMICAL AND IN KILOGRAMS

A Opening stock

B Total quantity manufactured

C Quantity imported and from which country

(Incl EU countries) ……………………………………
…………………………………..
………………………………….
…………………………………..
…………………………………..
………………………………….
…………………………………..
………………………………….
…………………………………..
…………………………………..
 ………………………………….
…………………………………..
………………………………….
…………………………………..
…………………………………..
………………………………….
…………………………………..

D Quantity exported and from which country

(Incl EU countries)….. …………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..

E Quantity supplied to UK licensees

F Quantity received from UK suppliers

G 1. Quantity used in the year…………………………………………

1(a) Purposes for which it was used

…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….

2. Quantity remaining in stock at 31 December 2013…………

H 1. Approximation of quantity required for use in 2013……………

2. Purposes for which it will be required.

…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
 …………………………………….

This form should be completed and returned to annualdrugreturns@hom

y to 31 December 2013

OPAN-2-ONE (PMK)…………………………………………………………………………

……………………………………

……………………………………

……………………………………

GRAMS

. KGS

· KGS

· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS

· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS

· KGS
· KGS

· KGS

. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS

· KGS

· KGS

. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
 . KGS

nualdrugreturns@homeoffice.gsi.gov.uk by 28 February 2013

 PRECURSORS
ANNUAL RETURN for the period 1 January to 31 December 2

NAME OF CHEMICAL…....…ISOSAFROLE ………………………………………………………

NAME OF COMPANY …………..……………………………………………………………………………

ADDRESS………………… ……………………..…………………………………………………………………

…………………………..……………………………………………………………

All quantities should be recorded in terms of BASE CHEMICAL AND IN KILOGRAMS

A Opening stock

B Total quantity manufactured

C Quantity imported and from which country

(Incl EU countries) ……………………………………
…………………………………..
………………………………….
…………………………………..
…………………………………..
………………………………….
…………………………………..
………………………………….
…………………………………..
…………………………………..
 ………………………………….
…………………………………..
………………………………….
…………………………………..
…………………………………..
………………………………….
…………………………………..

D Quantity exported and from which country

(Incl EU countries)….. …………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..

E Quantity supplied to UK licensees

F Quantity received from UK suppliers

G 1. Quantity used in the year…………………………………………

1(a) Purposes for which it was used

…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….

2. Quantity remaining in stock at 31 December 2013…………

H 1. Approximation of quantity required for use in 2013……………

2. Purposes for which it will be required.

…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
 …………………………………….

This form should be completed and returned to annualdrugreturns@hom

y to 31 December 2013

………………………………………………

……………………………………

……………………………………

……………………………………

GRAMS

. KGS

· KGS

· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS

· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS

· KGS
· KGS

· KGS

. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS

· KGS

· KGS

. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
 . KGS

nualdrugreturns@homeoffice.gsi.gov.uk by 28 February 2013

 PRECURSORS
ANNUAL RETURN for the period 1 January to 31 December 2

NAME OF CHEMICAL…....…PIPERONAL…………………………………………………………

NAME OF COMPANY …………..……………………………………………………………………………

ADDRESS………………… ……………………..…………………………………………………………………

…………………………..……………………………………………………………

All quantities should be recorded in terms of BASE CHEMICAL AND IN KILOGRAMS

A Opening stock

B Total quantity manufactured

C Quantity imported and from which country

(Incl EU countries) ……………………………………
…………………………………..
………………………………….
…………………………………..
…………………………………..
………………………………….
…………………………………..
………………………………….
…………………………………..
…………………………………..
 ………………………………….
…………………………………..
………………………………….
…………………………………..
…………………………………..
………………………………….
…………………………………..

D Quantity exported and from which country

(Incl EU countries)….. …………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..

E Quantity supplied to UK licensees

F Quantity received from UK suppliers

G 1. Quantity used in the year…………………………………………

1(a) Purposes for which it was used

…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….

2. Quantity remaining in stock at 31 December 2013…………

H 1. Approximation of quantity required for use in 2013……………

2. Purposes for which it will be required.

…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
 …………………………………….

This form should be completed and returned to annualdrugreturns@hom

y to 31 December 2013

……………………………………………

……………………………………

……………………………………

……………………………………

GRAMS

. KGS

· KGS

· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS

· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS

· KGS
· KGS

· KGS

. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS

· KGS

· KGS

. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
 . KGS

nualdrugreturns@homeoffice.gsi.gov.uk by 28 February 2013

 PRECURSORS
ANNUAL RETURN for the period 1 January to 31 December 2

NAME OF CHEMICAL…....…SAFROLE……………………………………………………………

NAME OF COMPANY …………..……………………………………………………………………………

ADDRESS………………… ……………………..…………………………………………………………………

…………………………..……………………………………………………………

All quantities should be recorded in terms of BASE CHEMICAL AND IN KILOGRAMS

A Opening stock

B Total quantity manufactured

C Quantity imported and from which country

(Incl EU countries) ……………………………………
…………………………………..
………………………………….
…………………………………..
…………………………………..
………………………………….
…………………………………..
………………………………….
…………………………………..
…………………………………..
 ………………………………….
…………………………………..
………………………………….
…………………………………..
…………………………………..
………………………………….
…………………………………..

D Quantity exported and from which country

(Incl EU countries)….. …………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..

E Quantity supplied to UK licensees

F Quantity received from UK suppliers

G 1. Quantity used in the year…………………………………………

1(a) Purposes for which it was used

…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….

2. Quantity remaining in stock at 31 December 2013…………

H 1. Approximation of quantity required for use in 2013……………

2. Purposes for which it will be required.

…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
 …………………………………….

This form should be completed and returned to annualdrugreturns@hom

y to 31 December 2013

…………………………………………

……………………………………

……………………………………

……………………………………

GRAMS

. KGS

· KGS

· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS

· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS

· KGS
· KGS

· KGS

. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS

· KGS

· KGS

. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
 . KGS

nualdrugreturns@homeoffice.gsi.gov.uk by 28 February 2013

 PRECURSORS
ANNUAL RETURN for the period 1 January to 31 December 2

NAME OF CHEMICAL…....…NOREPHEDRINE…………………………………………………

NAME OF COMPANY …………..……………………………………………………………………………

ADDRESS………………… ……………………..…………………………………………………………………

…………………………..……………………………………………………………

All quantities should be recorded in terms of BASE CHEMICAL AND IN KILOGRAMS

A Opening stock

B Total quantity manufactured

C Quantity imported and from which country

(Incl EU countries) ……………………………………
…………………………………..
………………………………….
…………………………………..
…………………………………..
………………………………….
…………………………………..
………………………………….
…………………………………..
…………………………………..
 ………………………………….
…………………………………..
………………………………….
…………………………………..
…………………………………..
………………………………….
…………………………………..

D Quantity exported and from which country

(Incl EU countries)….. …………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..

E Quantity supplied to UK licensees

F Quantity received from UK suppliers

G 1. Quantity used in the year…………………………………………

1(a) Purposes for which it was used

…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….

2. Quantity remaining in stock at 31 December 2013…………

H 1. Approximation of quantity required for use in 2013……………

2. Purposes for which it will be required.

…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
 …………………………………….

This form should be completed and returned to annualdrugreturns@hom

y to 31 December 2013

…………………………………………………

……………………………………

……………………………………

……………………………………

GRAMS

. KGS

· KGS

· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS

· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS

· KGS
· KGS

· KGS

. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS

· KGS

· KGS

. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
 . KGS

nualdrugreturns@homeoffice.gsi.gov.uk by 28 February 2013

 PRECURSORS
ANNUAL RETURN for the period 1 January to 31 December 2

NAME OF CHEMICAL…....…ACETIC ANHYDRIDE………………………………………………

NAME OF COMPANY …………..……………………………………………………………………………

ADDRESS………………… ……………………..…………………………………………………………………

…………………………..……………………………………………………………

All quantities should be recorded in terms of BASE CHEMICAL AND IN KILOGRAMS

A Opening stock

B Total quantity manufactured

C Quantity imported and from which country

(Incl EU countries) ……………………………………
…………………………………..
………………………………….
…………………………………..
…………………………………..
………………………………….
…………………………………..
………………………………….
…………………………………..
…………………………………..
 ………………………………….
…………………………………..
………………………………….
…………………………………..
…………………………………..
………………………………….
…………………………………..

D Quantity exported and from which country

(Incl EU countries)….. …………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..

E Quantity supplied to UK licensees

F Quantity received from UK suppliers

G 1. Quantity used in the year…………………………………………

1(a) Purposes for which it was used

…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….

2. Quantity remaining in stock at 31 December 2013…………

H 1. Approximation of quantity required for use in 2013……………

2. Purposes for which it will be required.

…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
 …………………………………….

This form should be completed and returned to annualdrugreturns@hom

y to 31 December 2013

………………………………………………………

……………………………………

……………………………………

……………………………………

GRAMS

. KGS

· KGS

· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS

· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS

· KGS
· KGS

· KGS

. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS

· KGS

· KGS

. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
 . KGS

nualdrugreturns@homeoffice.gsi.gov.uk by 28 February 2013

 PRECURSORS
ANNUAL RETURN for the period 1 January to 31 December 2

NAME OF CHEMICAL…....…POTASSIUM PERMANGANATE …………………………………

NAME OF COMPANY …………..……………………………………………………………………………

ADDRESS………………… ……………………..…………………………………………………………………

…………………………..……………………………………………………………

All quantities should be recorded in terms of BASE CHEMICAL AND IN KILOGRAMS

A Opening stock

B Total quantity manufactured

C Quantity imported and from which country

(Incl EU countries) ……………………………………
…………………………………..
………………………………….
…………………………………..
…………………………………..
………………………………….
…………………………………..
………………………………….
…………………………………..
…………………………………..
 ………………………………….
…………………………………..
………………………………….
…………………………………..
…………………………………..
………………………………….
…………………………………..

D Quantity exported and from which country

(Incl EU countries)….. …………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..
…………………………………..

E Quantity supplied to UK licensees

F Quantity received from UK suppliers

G 1. Quantity used in the year…………………………………………

1(a) Purposes for which it was used

…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….

2. Quantity remaining in stock at 31 December 2013…………

H 1. Approximation of quantity required for use in 2013……………

2. Purposes for which it will be required.

…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
…………………………………….
 …………………………………….

This form should be completed and returned to annualdrugreturns@hom

y to 31 December 2013

……………………………………………………………………

……………………………………

……………………………………

……………………………………

GRAMS

. KGS

· KGS

· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS

· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS
KGS
· KGS

· KGS
· KGS

· KGS

. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS

· KGS

· KGS

. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
. KGS
 . KGS

nualdrugreturns@homeoffice.gsi.gov.uk by 28 February 2013